European Medicines Agency Validates Marketing Authorization Application for Oral, Once-Daily Berotralstat (BCX7353) to Prevent HAE Attacks
Stock Information for BioCryst Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.